Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $12.10 USD
Change Today +0.04 / 0.33%
Volume 52.4K
TTOO On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael J. Cima Ph.D.

Co-Founder, Director, Member of Scientific Advisory Board, Member of Audit Committee and Member of Technology Committee,T2 Biosystems, Inc.
AgeTotal Calculated CompensationThis person is connected to 48 board members in 5 different organizations across 6 different industries.

See Board Relationships


Prof. Michael J. Cima, Ph.D., Co-founded Taris Biomedical, Inc. in 2008 and serves as its Scientific Advisor and also served as its Consultant. Mr. Cima is the Co-founder and Consultant of SpringLeaf Therapeutics, Inc. Dr. Cima served as a Senior Consultant and Senior Advisor at Transform Pharmaceuticals, Inc. He is a Professor of Materials Science and Engineering at the Massachusetts Institute of Technology (MIT) and an Investigator at the Koch Institute for Integrative ...

Read Full Background

Corporate Headquarters*

101 Hartwell Avenue
Lexington, Massachusetts 02421

United States

Phone: 718-491-3400
Fax: 781-357-3080

Board Members Memberships*

Director and Member of Scientific Advisory Board
Co-Founder, Consultant, Director
Co-Founder, Scientific Advisor and Director
Co-Founder, Director, Member of Scientific Advisory Board, Member of Audit Committee and Member of Technology Committee


PhD 1986
University of California Berkeley
BS 1982
University of California Berkeley

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$50,055
Total Calculated Compensation$50,055
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TTOO:US $12.10 USD +0.04


Hany Massarany Chief Executive Officer, President and Director
GenMark Diagnostics, Inc.
Douglas C. Bryant Chief Executive Officer, President and Director
Quidel Corp.
John A. Krauetler Chairman of The Board, Chief Executive Officer and President
Meridian Bioscience, Inc.
Michael K. McGarrity Chief Executive Officer, President and Director
Nanosphere, Inc.
Ryan Ashton Co-Founder, Chief Executive Officer, President and Director
Great Basin Scientific, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact T2 BIOSYSTEMS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at